CDEK
← All organizations

Day One Biopharmaceuticals, Inc.

For profitContributed to NMEWebsite ↗

Also known as: Day One Biopharmaceuticals, Inc. | DAY ONE BIOPHARMS

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Jun 1, 2018

First marketed drug

Apr 23, 2024

First NDA

Apr 23, 2024

Last known activity

Nov 18, 2024

Timeline

2010s

  1. Jun 1, 2018

    Day One Biopharmaceuticals, Inc.— Founded

2020s

  1. Apr 23, 2024

    tovorafenib— NDA Organization

Drugs by trial phase (10 distinct, 9 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Marketed drugs (1)

Recent trials (9)

Details

Founded
San Francisco, CA, US Jun 1, 2018
First NDA
Apr 23, 2024
Last known activity
Nov 18, 2024

Designations held

  • Orphan drug
  • Priority review
  • Breakthrough therapy
  • Accelerated approval